← Back
Data updated: Jun 28, 2026
ZMI PHARMA
Pharma Pharmaceuticals
ZMI PHARMA is a pharmaceutical company with 1 FDA-approved products.
2021
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules
ZMI PHARMA's Key Drugs
ZMI PHARMA's core commercial portfolio centers on ZIMHI — its most strategically important drugs approved in the last 15 years.
ZMI PHARMA's Recent FDA Approvals
New NDA/BLA approvals for ZMI PHARMA over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
ZMI PHARMA's Therapeutic Areas
Disease areas where ZMI PHARMA has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
ZMI PHARMA Pipeline Snapshot
Active clinical trials for ZMI PHARMA across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • ZIMHI leads revenue
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2021-10-15
- Latest
- 2021-10-15
- Applications
- 1